Read a summary of the 2021 virtual AADCH Congressional Briefing and Advocacy Day. Learn about legislative priorities to support people with asthma and allergies.
Making an Impact
Step Therapy Policies For Asthma and Allergies Are Failing Patients
The Network advocates against step therapy which limits patient treatment options, and can be dangerous and time-consuming. Learn what you can do about it.
35th Anniversary Gala and Benefit Concert with Little River Band – Washington, DC on May 6
May 6, 2020 – The Network invites you to the celebration of its 35th anniversary: an advocacy day on Capitol Hill; a gala dinner; awards; and a benefit concert.
Allergy & Asthma Day Capitol Hill – Washington, DC, May 6
The Network invites you to its annual Allergy & Asthma Day on Capitol Hill (AADCH20).
Little River Band to Perform Benefit Concert At Allergy & Asthma Network’s 35th Anniversary Gala
Legendary rock group Little River Band will perform a special benefit concert on Wednesday, May 6, for the Allergy & Asthma Network’s 35th anniversary.
A Recap of Asthma Funding in 2020 Budget
News regarding the Allergy & Asthma Network’s successful advocacy efforts leading to increases in federal program funding and policy provisions.
American Airlines is Stocking Auvi-Q in Medical Kits
The Network continues to advocate for airlines to stock epinephrine auto-injectors in emergency medical kits for the treatment of anaphylaxis.
Patients With Eczema Unite to Help Inform Drug Development
“More Than Skin Deep” initiative seeks to collect and share patient experiences to inform the drug development process and lead to better treatments.
Joint Statement on Peanut Allergy Therapy Review
The Network joins other patient organizations to urge ICER to consider patient needs when determining the value of emerging treatments for peanut allergy.
House Majority Leader Steny Hoyer Introduces School-Based Allergy and Asthma Management Legislation at AADCH
The Network’s 2019 Allergy and Asthma Day on Capitol Hill event connects advocates and legislators to drive change on key asthma and allergy issues.
FDA Decision to OK Primatene Mist Endangers Asthma Patients
The Network joins other advocacy organizations to express concern over the FDA’s approval of Primatene Mist(R) as treatment for mild, intermittent asthma.
Statement on EPA’s Proposed Clean Power Plan Repeal
The Network voices opposition on behalf of people with asthma regarding a proposed EPA rule that would increase the risk of more hazardous air pollutants.
All About
Making an Impact